Clinical Trials Browser

INDUSTRY × Prednisolone × 1 year × Clear all

Prostatic Neoplasms

Lymphoma, Large B-Cell, Diffuse

Prostatic Neoplasms

Lymphoma, B-Cell

Lymphoma, Follicular, Recurrence

Lymphoma, Large B-Cell, Diffuse

Adrenal Insufficiency, Myasthenia Gravis

Prostatic Neoplasms

Ovarian Neoplasms

Biliary Tract Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Lymphoma, Follicular

Hodgkin Disease

Lymphoma, Large B-Cell, Diffuse

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Lymphoma, Follicular

Lymphoma, Large B-Cell, Diffuse

Neoplasm Metastasis, Prostatic Neoplasms, Urogenital Neoplasms

Metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Clinical Trials

EvoPAR-PR02

MK-2140-011

MK-2400-001

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

LEDA

MK-2140-010

OCTAGON

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

OLYMPIA-1

MK-3475-667

OLYMPIA-3

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

rechARge

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL

CYCLONE 3

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

IPATential150

KEYLYNK-010